Aptamer therapeutics advance
Authors:
- 1 June 2006
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 10 (3) , 282-289
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Direct PCR amplification of various modified DNAs having amino acids: Convenient preparation of DNA libraries with high-potential activities for in vitro selectionBioorganic & Medicinal Chemistry, 2006
- Targeted inhibition of αvβ3 integrin with an RNA aptamer impairs endothelial cell growth and survivalBiochemical and Biophysical Research Communications, 2005
- Aptamers—basic research, drug development, and clinical applicationsApplied Microbiology and Biotechnology, 2005
- Selection of RNA aptamers against human influenza virus hemagglutinin using surface plasmon resonanceAnalytical Biochemistry, 2005
- Pharmacokinetics and Biodistribution of Novel Aptamer CompositionsPharmaceutical Research, 2004
- Sialyllactose-binding modified DNA aptamer bearing additional functionality by SELEXBioorganic & Medicinal Chemistry, 2004
- Spiegelmers: Biostable AptamersChemBioChem, 2003
- Prion-Protein-Specific Aptamer Reduces PrPSc FormationChemBioChem, 2002
- Bent Pseudoknots and Novel RNA Inhibitors of Type 1 Human Immunodeficiency Virus (HIV-1) Reverse TranscriptaseJournal of Molecular Biology, 1996
- Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypassThe Annals of Thoracic Surgery, 1994